Aprea Therapeutics Appoints John Hamill as Chief Financial
DOYLESTOWN, Pa., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical
Globe Newswire30-01-2023, 20:01
Inteleos to Host Roundtable on Advancing Maternal Health through Point-Of-Care-Ultrasound Certification 7-05-2024, 04:25